FTC Seeks To Protect Users’ Privacy On Period Tracker Apps

Federal Trade Commission Chair Lina Khan told lawmakers FTC is seeking to protect the privacy of health data collected by period tracker and other health apps as the Supreme Court appears poised to overturn the landmark abortion case Roe v Wade . Reproductive rights advocates worry that period tracker data will be used to investigate whether app users are receiving abortions in states where the procedure is criminalized. A number of states have passed or are pursuing laws criminalizing abortion,...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

Stakeholders Launch Group To Promote Digital Health Equity

A diverse group of stakeholders including drug makers, patient and physician advocacy groups, and historically black colleges and universities is launching a new coalition to promote equity in telemedicine. The Digital Health for Equitable Health Alliance (DHEH) will “champion policies and programs meant to increase equitable access to quality healthcare by building upon innovations in digital health, telemedicine, wearables, artificial intelligence, machine learning, and more to advance public health and well-being,” according to a press release . Organizations joining the...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 






Abortion Providers Irate Over Oklahoma ‘Bounty-Hunter’ Abortion Ban

The Oklahoma state legislature passed a bill to ban abortion beginning at fertilization and set up a so-called bounty-hunter provision to invoke civil suits against abortion providers or anyone who “aids or abets” an abortion. The bill, if signed by Republican Gov. Kevin Stitt, would take effect immediately and become the most-restrictive anti-abortion measure in the country. The bill, H.B.4327, adds to a slew of other restrictions in place in Oklahoma. An April 2022 law, S.B.612, made providing or attempting...
Article Type: 
Site Name: 
InsideHealthPolicy.com
CMS Issue: 
Inside CMS - 05/26/2022
CMS Volume: 
Vol. 25, No. 21
Author: 


Califf Shifts Veteran Drug-Specialist Woodcock To Shepherd Food Policy

FDA chief Robert Califf on Wednesday (May 18) announced that FDA Principal Deputy Commissioner Janet Woodcock will help shepherd key initiatives within the agency’s food center, coming as the agency races to resolve infant formula safety concerns and supply shortages caused by a recall of formula made by Abbott Nutrition. Woodcock, who spent nearly three decades as director of FDA’s drug center before taking on the role of acting FDA chief from 2021 to 2022, will help provide consistent leadership...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 05/27/2022
FDA Volume: 
Vol. 28, No. 21
Author: 

Appropriators Call For Leadership Changes At FDA’s Food Center

FDA needs to make significant structural and leadership changes at its food center, House appropriators on both sides of the aisle asserted during an FDA-agriculture appropriations subcommittee hearing Thursday (May 19). They questioned whether the agency should receive more funding to stand up new food programs or whether funding should focus on helping the agency fulfill its core duties, coming as the agency grapples with infant formula safety and shortage issues. FDA chief Robert Califf agreed that money won’t solve...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 05/27/2022
FDA Volume: 
Vol. 28, No. 21
Author: 

CDC Vaccine Panel Recommends Pfizer Booster Shot For Kids 5-11

The Centers for Disease Control and Prevention’s vaccine advisory committee on Thursday (May 19) said children ages 5 to 11 “should” receive a booster dose of Pfizer’s COVID-19 vaccine, building on FDA’s recent authorization of booster shots for the younger age group. The advisers voted 11-1, with one member abstaining, to recommend that children “should” receive the booster instead of simply saying that they “may,” in order to streamline communications and build confidence in the vaccine. Helen Talbot, an associate...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 05/27/2022
FDA Volume: 
Vol. 28, No. 21
Author: 

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.